Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Candelore

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|January 5, 1991
Allele-specific activation of genetically engineered receptorsC D Strader, T Gaffney, E E Sugg, et al.
The EMBO Journal|November 1, 1987
Structural features required for ligand binding to the beta-adrenergic receptorR A Dixon, I S Sigal, M R Candelore, et al.
Nature|March 5, 1987
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like coreR A Dixon, I S Sigal, E Rands, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptorD S Fletcher, M R Candelore, D Grujic, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Potent and selective human beta(3)-adrenergic receptor antagonistsM R Candelore, L Deng, L Tota, et al.
Proteins|January 1, 1989
Genetic analysis of the molecular basis for beta-adrenergic receptor subtype specificityR A Dixon, W S Hill, M R Candelore, et al.
Clinical Science (London, England : 1979)|April 21, 1999
Acute effect of ephedrine on 24-h energy balanceJ R Shannon, K Gottesdiener, J Jordan, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptorA E Weber, R J Mathvink, L Perkins, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonistE R Parmee, H O Ok, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moietiesL L Brockunier, M R Candelore, M A Cascieri, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|January 5, 1991
Allele-specific activation of genetically engineered receptorsC D Strader, T Gaffney, E E Sugg, et al.
The EMBO Journal|November 1, 1987
Structural features required for ligand binding to the beta-adrenergic receptorR A Dixon, I S Sigal, M R Candelore, et al.
Nature|March 5, 1987
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like coreR A Dixon, I S Sigal, E Rands, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptorD S Fletcher, M R Candelore, D Grujic, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Potent and selective human beta(3)-adrenergic receptor antagonistsM R Candelore, L Deng, L Tota, et al.
Proteins|January 1, 1989
Genetic analysis of the molecular basis for beta-adrenergic receptor subtype specificityR A Dixon, W S Hill, M R Candelore, et al.
Clinical Science (London, England : 1979)|April 21, 1999
Acute effect of ephedrine on 24-h energy balanceJ R Shannon, K Gottesdiener, J Jordan, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptorA E Weber, R J Mathvink, L Perkins, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonistE R Parmee, H O Ok, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moietiesL L Brockunier, M R Candelore, M A Cascieri, et al.
Pageof 4